Micallef Jacob Vincent 4
4 · VOLITIONRX LTD · Filed Jul 28, 2020
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Micallef Jacob Vincent
Chief Scientific Officer
Transactions
- Gift
Option (Right to Buy)
2020-07-27+65,000→ 65,000 totalExercise: $2.50From: 2015-02-18Exp: 2020-08-18→ Common Stock (65,000 underlying) - Gift
Option (Right to Buy)
2020-07-27+65,000→ 65,000 totalExercise: $3.00From: 2016-02-18Exp: 2020-08-18→ Common Stock (65,000 underlying) - Gift
Option (Right to Buy)
2020-07-27−65,000→ 0 total(indirect: Borlaug Limited)Exercise: $2.50From: 2015-02-18Exp: 2020-08-18→ Common Stock (65,000 underlying) - Gift
Option (Right to Buy)
2020-07-27−65,000→ 0 total(indirect: Borlaug Limited)Exercise: $3.00From: 2016-02-18Exp: 2020-08-18→ Common Stock (65,000 underlying) - Gift
Option (Right to Buy)
2020-07-27−55,000→ 0 total(indirect: Borlaug Limited)Exercise: $4.00From: 2016-01-23Exp: 2021-07-23→ Common Stock (55,000 underlying) - Gift
Option (Right to Buy)
2020-07-27+55,000→ 55,000 totalExercise: $4.00From: 2016-01-23Exp: 2021-07-23→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Borlaug Limited ("Borlaug"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the "2011 Plan"). Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020.
- [F2]The option to purchase 55,000 shares of Common Stock of the Issuer was granted to Borlaug on July 23, 2015 under the Issuer's 2011 Plan. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020.